Search Results

BioMidwest

NxGen MDx Announces Monkeypox Testing in Michigan and Chicago

NxGen MDx begins offering testing in Michigan and Chicago, IL for monkeypox, shingles, and lesion-forming STIs including chancroid, syphilis, and herpes.

August 10, 2022

·

3 min read

NxGen MDx Announces New Early Advantage Carrier Screening Panel

NxGen MDx is taking an innovative approach to genetic carrier screening panel design by creating the Early Advantage Panel.

September 15, 2021

·

3 min read

Business

NxGen MDx Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools

Today, NxGen MDx announced a partnership with Concentric by Ginkgo to provide COVID-19 testing to congregate settings such as schools operating in-person or hybrid learning environments using a scalable and simple testing modality - pooled testing.

April 12, 2021

·

2 min read

Biotech Beach

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test

MDxHealth SA, a commercial-stage precision diagnostics company, announced that Cigna has expanded commercial and Medicare Advantage coverage to include the Company’s Select mdx for Prostate Cancer test.

August 9, 2023

·

6 min read

BioMidwest

NxGen MDx announces the immediate launch and availability of their COVID-19 Test.

To combat the lack of availability of tests, NxGen MDx announces the immediate launch and availability of their COVID-19 test.

March 23, 2020

·

1 min read

Biotech Beach

Foundational LCD Covers Select mdx for Prostate Cancer

MDxHealth SA, a commercial-stage precision diagnostics company, received notice that its Select mdx for Prostate Cancer test has successfully completed a rigorous technical assessment process with the Molecular Diagnostics Services Program developed by Palmetto GBA.

April 19, 2023

·

5 min read

Business

State of Michigan recommends partnering with NxGen MDx for COVID-19 testing

The Michigan Department of Health and Human Services (MDHHS) is recommending that healthcare providers across the state partner with NxGen MDx in order to maximize the availability of COVID-19 testing.

April 22, 2020

·

1 min read

BioMidwest

NxGen MDx announces Urogenital Pathogens Tests with a turnaround of 24 hours

NxGen MDx announced the launch of their Urogenital Pathogens Tests, a group of women’s health tests.

November 6, 2019

·

2 min read

BioMidwest

NxGen MDx implements hereditary cancer panel

NxGen MDx announced the creation of the NxGen MDx Hereditary Cancer Panel, which will test for variants in 32 genes known to cause certain forms of hereditary cancer.

October 25, 2018

·

1 min read

Biotech Beach

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only

Applied BioCode now offers STI + Resistance Panel on the BioCode® MDx-3000 system for research use only (RUO).

April 15, 2024

·

4 min read